Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHP-101 in Relapsing Forms of Multiple Sclerosis
NCT04909502Phase 2Suspended
- Sponsor
- Emerald Health Pharmaceuticals Inc.
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of etrinabdione in multiple sclerosis (MS), sponsored by Emerald Health Pharmaceuticals Inc.. Started Oct 2021; status: suspended.
02
Drugs
etrinabdione
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04909502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04909502.